LEUKOS BIOTECH SL
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
LEUKOS BIOTECH
We focus on developing new treatments and diagnostic tools for leukaemia. we have identified a new therapeutic target against leukemic stem cells in aml which will be validated, using a repurposed small molecule, in a phase ii clinical trial starting at the end of 2017. the study will also cover the diagnosis and prognosis of aml patients according to the expression of this biomarker in blood.
Industries & Technologies
Financial data
Other information
Funding
3.5M € (September 2016)
Minority stake unknown %
Investors: INVEREADY, PRIVATE INVESTOR
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
@LeukosBiotech
Other startups near startup LEUKOS BIOTECH
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.